[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100485194":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":24,"locations":30,"responsibleParty":49,"collaborators":52,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":10,"eligibilityCriteria":73,"healthyVolunteers":74,"sex":75,"minAge":76,"maxAge":10,"enrollmentInfo":77,"targetDuration":10,"studyType":80,"phases":10,"briefSummary":81,"conditions":82,"keywords":85,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Tampere University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Coeliac disease patients",null,"Adult (18 years or over) patients with previous coeliac disease or dermatitis herpetiformis diagnosis",[13],"Genetic: Genetic predisposition",{"label":15,"type":10,"description":16,"interventionNames":17},"Healthy controls","500 adult (18 years or over) friends or non-related family members of coeliac disease or dermatitis herpetiformis patients participating in the study, no previous coeliac disease or dermatitis herpetiformis diagnosis. In addition 1000 controls will be included from Biobank",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"GENETIC","Genetic predisposition","Assessment of genetic predisposition to various celiac disease phenotypes. No intervention.",[9,15],[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Teea T Salmi, Prof","CONTACT","+358503016355","teea.salmi@pshp.fi",[31],{"facility":5,"status":32,"city":33,"state":10,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"RECRUITING","Tampere","33521","Finland","FI",{"type":38,"coordinates":39},"Point",[40,41],23.78712,61.49911,{"lat":41,"lon":40},[44,47],{"name":26,"role":27,"phone":45,"phoneExt":10,"email":46},"+358 503016355","teea.salmi@tuni.fi",{"name":26,"role":48,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":48,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Teea Salmi","Professor in Dermatology",[53,55,57,59,61,63,65],{"name":54,"class":6},"Tampere University",{"name":56,"class":6},"University of Helsinki",{"name":58,"class":6},"University of Turku",{"name":60,"class":6},"Oulu University Hospital",{"name":62,"class":6},"University of Debrecen",{"name":64,"class":6},"University of Trieste",{"name":66,"class":6},"Oslo University Hospital","100485194","background-of-different-phenotypes-of-coeliac-disease-100485194",false,"NCT05597904","Background of Different Phenotypes of Coeliac Disease","Genetic and Biological Background and Follow-up of Different Phenotypes of Coeliac Disease","Inclusion Criteria:\n\n* Cohorts 1 and 2: coeliac disease or dermatitis herpetiformis diagnosis\n* Cohort 3: friend or non-related family member of coeliac disease or dermatitis herpetiformis patient\n\nExclusion Criteria:\n\n* Cohorts 1-3: Age \\\u003C18 years\n* Cohorts 1 and 2: coeliac disease or dermatitis herpetiformis diagnosis not confirmed\n* Cohort 3: coeliac disease or dermatitis herpetiformis diagnosis",true,"ALL","18 Years",{"count":78,"type":79},3500,"ESTIMATED","OBSERVATIONAL","The main purpose of this study is to investigate genetic, serological, immunological and microbiata diversities between different coeliac disease phenotypes and to discover applicable prognostic markers for specific phenotypes.",[83,84],"Celiac Disease","Dermatitis Herpetiformis",[86,87,88,89,90],"coeliac disease","dermatitis herpetiformis","gluten-free diet","transglutaminase","microbiata","2025-09-10",{"date":93,"type":94},"2025-09-17","ACTUAL",{"date":96,"type":94},"2022-11-08",{"date":98,"type":79},"2030-12-31",{"name":5,"class":6},1]